GB Patent

GB202401392D0 — Implant for delivery of a drug

Assigned to Imphatec Ltd · Expires 2024-03-20 · 2y expired

What this patent protects

Patent listed against Gemzar.

Drugs covered by this patent

Gemzar (Gemcitabine Hydrochloride) · Accord Hlthcare

Patent Metadata

Patent number: GB202401392D0
Jurisdiction: GB
Classification: —
Expires: 2024-03-20
Drug substance claim: No
Drug product claim: No
Assignee: Imphatec Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.